NPS Pharmaceuticals, Inc.
550 Hills Drive
3rd Floor
Bedminster,
NJ 07921
United States - Map
Phone: 908-450-5300
Fax: 908-450-5351
Website: http://www.npsp.com
NPS Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for gastrointestinal and endocrine disorders, and various medical needs. The companys primary clinical programs include two therapeutic peptides to restore or replace biological functions comprising GATTEX, a Phase 3 clinical trial product for short bowel syndrome; and Natpara, a recombinant human parathyroid hormone 1-84, which is in Phase 3 clinical development trials. It also develops NPSP790 and NPSP795 calcilytic compounds that are in Phase I trials for the treatment of rare endocrine disorders. The company has collaborative and license agreements with Amgen Inc., Janssen, GlaxoSmithKline, Kyowa Hakko Kirin, and Nycomed Danmark ApS. NPS Pharmaceuticals, Inc. was founded in 1986 and is based in Bedminster, New Jersey. Key Statistics
| |
| NPS Pharmaceuticals, Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (Medium Concern), Shareholder Rights (Low Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Dr. Francois Nader M.D., M.B.A.,
55
Chief Exec. Officer, Pres and Director | 1.02M | 0.00 | Mr. Luke M. Beshar CPA,
53
Chief Financial Officer, Exec. VP and Principal Accounting Officer | 532.00K | 298.00K | Dr. Roger J. Garceau M.D., FAAP,
58
Chief Medical Officer and Sr. VP of R&D | 518.00K | 0.00 | Mr. Eric Pauwels ,
50
Chief Commercial Officer and Sr. VP | 276.00K | 0.00 | Dr. Bo Joelsson M.D., Ph.D.,
Head of Clinical Research | N/A | N/A |
|
| | Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.60% Nasdaq